Irbesartan Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The irbesartan market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Irbesartan is a type of drug known as an angiotensin II receptor blocker (ARB). It works by relaxing the blood vessels so that blood can flow more easily through them, it is used to treat high blood pressure, heart failure, and kidney disease. The growth of the market can be attributed to various factors such as an increase in the prevalence of hypertension and other cardiovascular diseases, a rise in awareness about the benefits of irbesartan drugs, and increasing R&D expenditure by pharmaceutical companies The increase in the prevalence of Kidney disease has created a demand for the irbesartan market for its treatment.

Key players in the irbesartan market include AbbVie Inc., Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Eli Lilly & Co., and Takeda Pharmaceutical Co. Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market.For instance, in September 2019, there are 11 Irbesartan API manufacturers, as well as 24 manufacturers of Irbesartan tablets, capsules, and dispersed tablets in China. Sanofi Irbesartan Products and its subsidiary Sanofi (Hangzhou) Pharmaceutical Co., Ltd. has a huge profit in China, accounting for about 80 of the market share by sales price in 2018, which increased the demand of the irbesartan market.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape-AbbVie Inc., Daiichi Sankyo Co. Ltd., Eisai Co. Ltd., Eli Lilly & Co., Takeda Pharmaceutical Co. Ltd., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global IrbesartanMarket Report by Segment

By Type

• Combination Drugs
• Prescribed Drugs

By Application

• Hyperlipidemia
• High Blood Pressure
• Heart Failure
• Kidney Disease
• Fibrous Fibrillation
• Other